Suchergebnisse - Ronit Simantov

Treffer weiter einschränken
  1. 1
    Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

    Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1 von Ronit Simantov, Maria Febbraio, René Crombie, Adam S. Asch, Ralph L. Nachman, Roy L. Silverstein

    Veröffentlicht 2001
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database

    Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database von André P. Fay, Rana R. McKay, Xun Lin, Ronit Simantov, Toni K. Choueiri

    Veröffentlicht 2018
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II

    High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II von Keying Ma, Ronit Simantov, Jing-Chuan Zhang, Roy L. Silverstein, Katherine A. Hajjar, Keith R. McCrae

    Veröffentlicht 2000
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma

    Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma von Rana R. McKay, Xun Lin, Julia Jane Perkins, Daniel Y.C. Heng, Ronit Simantov, Toni K. Choueiri

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

    Activation of cultured vascular endothelial cells by antiphospholipid antibodies. von Ronit Simantov, J M LaSala, S K Lo, A E Gharavi, Lisa R. Sammaritano, Jane E. Salmon, Roy L. Silverstein

    Veröffentlicht 1995
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Depth of Remission is a Prognostic Factor for Survival in Patients with Metastatic Renal Cell Carcinoma

    Depth of Remission is a Prognostic Factor for Survival in Patients with Metastatic Renal Cell Carcinoma von Viktor Grünwald, Rana R. McKay, Katherine M. Krajewski, D. Kalanovic, Xun Lin, Julia Jane Perkins, Ronit Simantov, Toni K. Choueiri

    Veröffentlicht 2015
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo

    Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo von Ling Qi, Andrew T. Jacovina, Arunkumar B. Deora, Maria Febbraio, Ronit Simantov, Roy L. Silverstein, Barbara Hempstead, Willie Mark, Katherine A. Hajjar

    Veröffentlicht 2004
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma

    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma von Rana R. McKay, Gustavo E. Rodriguez, Xun Lin, Marina D. Kaymakcalan, Ole‐Petter R. Hamnvik, Venkata Sabbisetti, Rupal S. Bhatt, Ronit Simantov, Toni K. Choueiri

    Veröffentlicht 2015
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice

    Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice von Hayes M. Dansky, Sherri A. Charlton, John L. Sikes, Simon Heath, Ronit Simantov, Lawrence F. Levin, Pei Shu, Karen J. Moore, Jan L. Breslow, Jonathan D. Smith

    Veröffentlicht 1999
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors

    A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors von Igor Puzanov, Colin R. Lindsay, Laura W. Goff, Jeff Sosman, Jill Gilbert, Jordan Berlin, Srinivasu Poondru, Ronit Simantov, Rich Gedrich, Andrew Stephens, Emily Chan, T.R. Jeffry Evans

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer

    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer von Alex A. Adjei, Julian R. Molina, Sumithra J. Mandrekar, Randolph S. Marks, Joel R. Reid, Gary A. Croghan, Lorelei J. Hanson, James R. Jett, Chenghua Xia, Chetan Lathia, Ronit Simantov

    Veröffentlicht 2007
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer

    Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer von April A. N. Rose, Andrée‐Anne Grosset, Zhifeng Dong, Caterina Russo, Patricia MacDonald, Nicholas Bertos, Yves St‐Pierre, Ronit Simantov, Michael Hallett, Morag Park, Louis Gaboury, Peter M. Siegel

    Veröffentlicht 2010
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors

    Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors von Robin L. Jones, Edward S. Kim, Pilar Nava-Parada, Salma Alam, Faye M. Johnson, Andrew Stephens, Ronit Simantov, Srinivasu Poondru, Rich Gedrich, Scott M. Lippman, Stan B. Kaye, Craig P. Carden

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus

    Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus von Mary J. Roman, Beth‐Ann Shanker, Adrienne Davis, Michael D. Lockshin, Lisa R. Sammaritano, Ronit Simantov, Mary K. Crow, Joseph E. Schwartz, Stephen A. Paget, Richard B. Devereux, Jane E. Salmon

    Veröffentlicht 2003
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Statins and survival outcomes in patients with metastatic renal cell carcinoma

    Statins and survival outcomes in patients with metastatic renal cell carcinoma von Rana R. McKay, Xun Lin, Laurence Albigès, André P. Fay, Marina D. Kaymakcalan, Suzanne S Mickey, P. Peter Ghoroghchian, Rupal S. Bhatt, Samuel Kaffenberger, Ronit Simantov, Toni K. Choueiri, Daniel Yick Chin Heng

    Veröffentlicht 2015
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma von Patrick A. Ott, Omid Hamid, Anna C. Pavlick, Harriet M. Kluger, Kevin B. Kim, Peter D. Boasberg, Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, Thomas A. Davis, Mario Sznol, Patrick Hwu

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer

    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer von Johanna C. Bendell, Mansoor N. Saleh, April A. N. Rose, Peter M. Siegel, Lowell L. Hart, Surendra Sirpal, Suzanne F. Jones, Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, Thomas A. Davis, Linda T. Vahdat

    Veröffentlicht 2014
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis von Tim Eisen, T. Ahmad, Keith T. Flaherty, Martin Gore, Stan B. Kaye, Richard Marais, I. Gibbens, Samuel Hackett, Maggie James, Lynn M. Schuchter, Katherine L. Nathanson, Chenjing Xia, Ronit Simantov, Brian Schwartz, Melanie Poulin-Costello, Peter J. O’Dwyer, Mark J. Ratain

    Veröffentlicht 2006
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma

    Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma von Aly‐Khan A. Lalani, Wanling Xie, David A. Braun, Marina D. Kaymakcalan, Dominick Bossé, John A. Steinharter, Dylan J. Martini, Ronit Simantov, Xun Lin, Xiao X. Wei, Bradley A. McGregor, Rana R. McKay, Lauren C. Harshman, Toni K. Choueiri

    Veröffentlicht 2019
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

    Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma von Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, M. Siebels, Sylvie Négrier, Christine Chevreau, E Solska, Apurva A. Desai, Frédéric Rolland, Tomasz Demkow, Thomas E. Hutson, Martin Gore, Sara M. Freeman, Brian Schwartz, Minghua Shan, Ronit Simantov, Ronald M. Bukowski

    Veröffentlicht 2007
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: